Semin Thromb Hemost 2023; 49(02): 182-191
DOI: 10.1055/s-0042-1753513
Review Article

The Utility of NATEM Assay in Predicting Bleeding Risk in Critically Ill Neonates

Rozeta Sokou*
1   Neonatal Intensive Care Unit, “Agios Panteleimon” General Hospital of Nikea, Piraeus, Greece
,
Petroula Georgiadou*
1   Neonatal Intensive Care Unit, “Agios Panteleimon” General Hospital of Nikea, Piraeus, Greece
,
Andreas G. Tsantes*
2   Laboratory of Haematology and Blood Bank Unit, “Attiko” Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
,
Stavroula Parastatidou
1   Neonatal Intensive Care Unit, “Agios Panteleimon” General Hospital of Nikea, Piraeus, Greece
,
Aikaterini Konstantinidi
1   Neonatal Intensive Care Unit, “Agios Panteleimon” General Hospital of Nikea, Piraeus, Greece
,
Georgios Ioakeimidis
1   Neonatal Intensive Care Unit, “Agios Panteleimon” General Hospital of Nikea, Piraeus, Greece
,
Athanasia Makrogianni
1   Neonatal Intensive Care Unit, “Agios Panteleimon” General Hospital of Nikea, Piraeus, Greece
,
Martha Theodoraki
1   Neonatal Intensive Care Unit, “Agios Panteleimon” General Hospital of Nikea, Piraeus, Greece
,
Styliani Kokoris
2   Laboratory of Haematology and Blood Bank Unit, “Attiko” Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
,
Nicoletta Iacovidou
3   Neonatal Department, Aretaieio Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Anastasios G. Kriebardis
4   Laboratory of Reliability and Quality Control in Laboratory Hematology, Department of Biomedical Science, School of Health and Caring Science, University of West Attica, Egaleo, Athens, Greece
,
Daniele Piovani
5   Department of Biomedical Sciences, Humanitas University, Milan, Italy
6   IRCCS Humanitas Research Hospital, Milan, Italy
,
Stefanos Bonovas
5   Department of Biomedical Sciences, Humanitas University, Milan, Italy
6   IRCCS Humanitas Research Hospital, Milan, Italy
,
Argirios E. Tsantes
2   Laboratory of Haematology and Blood Bank Unit, “Attiko” Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
› Institutsangaben
Preview

Abstract

We aimed to investigate the hemostatic status of diseased neonates using nonactivated rotational thromboelastometry (ROTEM) assay (NATEM) assay and, in addition, to evaluate the discriminative power of NATEM parameters in predicting the risk of bleeding in critically ill neonates and compare it to that of EXTEM (extrinsically activated ROTEM) parameters. This cohort study included 158 consecutive, critically ill neonates with presumed sepsis, perinatal hypoxia, or respiratory distress syndrome. The EXTEM and NATEM assays were performed on the first day of disease onset. The neonatal bleeding assessment tool was used to record and assess clinical bleeding events on the day of ROTEM analysis. Several EXTEM and NATEM ROTEM parameters differed between neonates with and without clinical bleeding events, indicating a hypo-coagulable state in neonates with clinical bleeding. NATEM parameters had comparable predictive performance for clinical bleeding events with EXTEM parameters for clotting time, clot formation time (CFT), A10 (clot amplitude at 10minutes), maximum clot firmness, lysis index at 60minutes, and maximum clot elasticity (p>0.05). However, NATEM A20, A30, and α angle demonstrated better predictive ability than EXTEM A20, A30, and α angle, respectively (p<0.05). A NATEM CFT value ≥147seconds presented 95.2% sensitivity (95% confidence interval [CI]: 76.1–99.8%) and 65.6% specificity (95% CI: 57.1–73.5%) to detect neonates with clinical bleeding, while a NATEM A10 value ≤42mm had 80.8% sensitivity (95% CI: 71.8–85.9%) and 76.0% specificity (95% CI: 52.8–91.7%) to detect neonates with clinical bleeding events. The NATEM assay has shown remarkable sensitivity in predicting bleeding in critically ill neonates, exceeding EXTEM performance in some selected parameters. The incorporation of NATEM test parameters in predictive models for neonatal hemorrhage seems promising.

Ethics Approval

The study protocol was approved by the Institutional Review Board of Nikea General Hospital (152/2017, 14/4/2017). Informed consent has been obtained from parents or guardians of enrolled neonates.


Authors' Contributions

R.S. and A.E.T. conceived the study. All authors contributed to the design of the study protocol. R.S., P.G., A.K., G.I., S.P., A.M., N.I., M.T., S.K., and A.G.K. conducted the work and collected the data. A.G.T., S.B., and D.P. performed the statistical analysis. All authors contributed to the interpretation of data for the work. R.S., A.G.T., S.P., P.G., and A.E.T. drafted the manuscript. All authors critically revised the manuscript for important intellectual content and approved the final version to be published.


* These authors contributed equally to this work.




Publikationsverlauf

Artikel online veröffentlicht:
02. September 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA